The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential ...

Passive income investors like me are always on the lookout for different ways to generate extra income. If you can make your ...

The world of investing involves uncertainty, volatility, and ever-changing macroeconomic conditions. In such scenarios, ...

Importantly, Pfizer Inc. (NYSE:PFE) does carry debt. But is this debt a concern to shareholders? We've found 21 US stocks ...

With continued uncertainty over Washington's policy priorities plus a recent flare-up of geopolitical tensions in the Middle East, it seems like Wall Street may continue to focus on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.